Profile data is unavailable for this security.
About the company
SEIKAGAKU CORPORATION is principally engaged in the research, development, purchase, manufacture and sale of pharmaceutical products and limulus amebocyte lysate (LAL). The Company operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic operation boosters and submucosal injection materials for endoscopes, as well as drug substances for various pharmaceuticals. The LAL business segment provides reagents for measuring endotoxin.
- Revenue in JPY (TTM)34.68bn
- Net income in JPY1.31bn
- Incorporated1947
- Employees976.00
- LocationSeikagaku Corp10F, Marunouchi Center Bldg1-6-1, MarunouchiCHIYODA-KU 100-0005JapanJPN
- Phone+81 352208950
- Fax+81 352208951
- Websitehttps://www.seikagaku.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fuso Pharmaceutical Industries Ltd | 54.63bn | 1.34bn | 20.92bn | 1.31k | 14.29 | 0.5193 | 5.94 | 0.3831 | 154.89 | 154.89 | 6,295.26 | 4,263.41 | 0.725 | 3.31 | 2.20 | 41,572,300.00 | 1.78 | 1.79 | 2.95 | 2.87 | 25.29 | 27.78 | 2.45 | 2.59 | 1.09 | 65.13 | 0.2835 | 45.95 | 2.79 | 2.14 | 8.23 | 10.60 | -1.72 | -2.64 |
| Medical Data Vision Co Ltd | 6.42bn | 979.13m | 23.58bn | 262.00 | 22.98 | 5.29 | 22.32 | 3.67 | 25.63 | 25.63 | 168.05 | 111.30 | 1.15 | 140.01 | 6.11 | 24,500,100.00 | 17.17 | 16.16 | 24.01 | 20.88 | 78.38 | 81.90 | 14.87 | 15.52 | 2.58 | 24.66 | 0.00 | 19.98 | 5.15 | 12.40 | 12.48 | 69.75 | -23.95 | -- |
| Pharma Foods International Co., Ltd. | 65.08bn | 4.76bn | 24.11bn | 670.00 | 5.02 | 2.53 | 4.49 | 0.3704 | 165.17 | 165.17 | 2,257.80 | 327.80 | 1.84 | 2.22 | 12.71 | 97,135,820.00 | 13.44 | 8.40 | 48.12 | 19.20 | 79.89 | 81.34 | 7.32 | 3.85 | 0.8449 | 91.33 | 0.6839 | 28.26 | 13.94 | 53.90 | 923.80 | 57.92 | 51.63 | -- |
| Cuorips Inc | 39.89m | -598.68m | 26.14bn | 46.00 | -- | 4.32 | -- | 655.40 | -76.49 | -76.49 | 5.13 | 766.30 | 0.0081 | 3.93 | 39.73 | 867,130.40 | -12.10 | -- | -12.39 | -- | 45.79 | -- | -1,500.91 | -- | 35.89 | -- | 0.00 | -- | 175.12 | -- | -20.45 | -- | -- | -- |
| StemRIM Inc | 2.35bn | 179.40m | 26.74bn | 44.00 | 127.07 | 2.72 | -- | 11.38 | -0.1097 | -0.1097 | 37.43 | 159.71 | 0.2453 | -- | -- | 53,409,090.00 | 1.87 | -6.71 | 1.89 | -6.83 | -- | -- | 7.63 | -45.80 | 78.90 | 652.72 | 0.00 | -- | 10,128.06 | 63.68 | 108.64 | -- | -- | -- |
| SanBio Co Ltd | 0.00 | -2.64bn | 28.34bn | 29.00 | -- | 10.05 | -- | -- | -40.50 | -40.50 | 0.00 | 41.11 | 0.00 | -- | -- | 0.00 | -43.74 | -42.00 | -52.38 | -48.88 | -- | -- | -- | -4,790.72 | -- | -- | 0.1923 | -- | -- | -- | 52.44 | -- | 53.94 | -- |
| Mizuho Medy Co Ltd | 10.99bn | 3.77bn | 31.62bn | 180.00 | 8.38 | 2.02 | 7.97 | 2.88 | 396.27 | 396.27 | 1,153.85 | 1,645.86 | 0.5776 | 2.04 | 2.04 | 61,054,080.00 | 19.84 | 31.46 | 23.70 | 39.78 | 73.47 | 74.85 | 34.34 | 33.64 | 6.45 | -- | 0.00 | 34.83 | -37.49 | 11.34 | -51.85 | 32.64 | -17.74 | 32.85 |
| Koa Shoji Holdings Co Ltd | 22.27bn | 2.86bn | 32.73bn | 297.00 | 11.46 | 1.49 | 9.19 | 1.47 | 72.09 | 72.09 | 562.08 | 554.93 | 0.7777 | 5.99 | 2.42 | 74,979,020.00 | 9.97 | 7.91 | 12.38 | 9.93 | 30.12 | 28.74 | 12.83 | 10.48 | 3.69 | 29.24 | 0.1197 | 19.64 | 8.35 | 8.27 | 13.90 | 29.60 | -21.26 | 15.52 |
| Fuji Pharma Co Ltd | 41.64bn | 5.06bn | 38.20bn | 1.62k | 7.41 | 0.8936 | 4.65 | 0.9173 | 208.19 | 208.19 | 1,713.27 | 1,726.70 | 0.5039 | 1.40 | 2.82 | 25,687,230.00 | 6.12 | 4.10 | 8.90 | 5.58 | 38.51 | 42.41 | 12.15 | 7.55 | 0.7165 | -- | 0.3947 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
| Daito Pharmaceutical Co Ltd | 45.19bn | 3.28bn | 39.09bn | 1.01k | 11.98 | 0.7519 | 5.75 | 0.8649 | 207.85 | 207.85 | 2,864.81 | 3,311.81 | 0.6193 | 1.81 | 2.65 | 44,701,280.00 | 4.35 | 6.99 | 5.64 | 9.29 | 21.38 | 22.71 | 7.03 | 8.83 | 1.15 | -- | 0.1231 | 17.08 | 3.77 | 2.49 | -22.88 | 3.43 | 7.48 | 12.70 |
| Seikagaku Corp | 34.68bn | 1.31bn | 41.76bn | 976.00 | 30.62 | 0.5592 | 14.43 | 1.20 | 24.00 | 24.00 | 635.69 | 1,314.47 | 0.4431 | 1.75 | 4.31 | 35,530,740.00 | 1.67 | 0.438 | 1.80 | 0.4797 | 50.52 | 55.91 | 3.77 | 1.07 | 5.44 | -- | 0.0055 | 452.20 | -4.00 | 2.09 | -40.10 | -10.63 | 8.40 | 0.00 |
| Shin Nippon Biomedical Laboratories Ltd | 26.70bn | 5.50bn | 61.62bn | 1.21k | 11.20 | 2.04 | 8.46 | 2.31 | 132.18 | 132.18 | 641.45 | 725.03 | 0.4107 | 1.27 | 5.55 | 22,105,960.00 | 8.46 | 9.47 | 12.30 | 14.34 | 52.19 | 50.00 | 20.60 | 24.39 | 0.9618 | -- | 0.4687 | 23.01 | 41.37 | 8.61 | -14.98 | -- | 37.23 | -- |
Data as of Apr 26 2024. Currency figures normalised to Seikagaku Corp's reporting currency: Japanese Yen JPY
17.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Invesco Asset Management (Japan) Ltd.as of 30 Sep 2023 | 5.27m | 9.28% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 1.22m | 2.15% |
| Nomura Asset Management Co., Ltd.as of 29 Mar 2024 | 1.07m | 1.88% |
| Dimensional Fund Advisors LPas of 28 Mar 2024 | 510.30k | 0.90% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 488.90k | 0.86% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 474.60k | 0.84% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 298.60k | 0.53% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 2024 | 208.20k | 0.37% |
| Bessemer Investment Management LLCas of 31 Jan 2024 | 125.20k | 0.22% |
| Charles Schwab Investment Management, Inc.as of 04 Apr 2024 | 80.20k | 0.14% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
